Areas of Abstract Submission


Submission of abstracts in the following areas is encouraged:

Basic Science of Clinical Pharmacology
  • Clinical Pharmacokinetics (ADME)
  • Drug Interactions
  • Experimental Pharmacology in In Vitro/In Vivo Studies
  • Human Pharmacology
  • Mechanism of Action
  • Pharmacogenomics
  • Pharmacodynamics
  • Therapeutic Drug Monitoring
  • Translational Medicine (Biomarkers/Imaging)
  • Transporters
Quantitative
  • Applications of Modeling & Simulation
  • Big Data Science & Analytics
  • Digital Health
  • Emerging Technologies
  • Innovative Statistical Methods
  • Pharmacometrics & Systems Pharmacology
  • Precision Medicine
Drug Development
  • Biosimilars
  • Clinical Trials
  • Decision Making in Research & Development
  • Drug Development
  • Model-informed Drug Development
  • New & Adaptive Clinical Trial Designs
  • Novel Use of Therapeutics/Drug Repurposing
  • Regulatory Issues
Applied Clinical Pharmacology Techniques
  • Adverse Drug Effects
  • Drug Effectiveness
  • Pharmacoeconomics
  • Pharmacoepidemiology
  • Quality of Life
  • Real-world Evidence in Decision Making
  • Risk Management/Legal Issues
  • Safety & Efficacy
Therapeutic Areas of Applied Clinical Pharmacology
  • Disease Management
  • Drug Dependence
  • HIV/AIDS
  • Immunology/Immunotherapy
  • Infectious Diseases
  • Oncology/Immuno-oncology
  • Other Therapeutic Areas
  • Rare Diseases
  • Pediatrics
  • Special Populations
  • Women’s Health
Unique
  • Clinical Pharmacology Education

 

Primary criteria for acceptance of abstracts are:

  • Applicability to clinical pharmacology and translational medicine;
  • Innovation and scientific merit;
  • Relevance to ACCP's mission.

Each abstract must contain:

  • A statement of purpose, innovation or hypothesis;
  • Description of methods and materials;
  • Data and results;
  • Interpretation, conclusion and significance.